Cargando…
Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
Overactive bladder syndrome (OAB) is a constellation of distressing symptoms that significantly impair quality of life, sexual function, and work productivity, and imposes a significant economic burden to society. Pharmacological treatment with antimuscarinic agents, behavioral modification, bladder...
Autores principales: | Gamble, Tondalaya, Sand, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770388/ https://www.ncbi.nlm.nih.gov/pubmed/19920982 |
Ejemplares similares
-
Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006) -
Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
por: Vozmediano-Chicharro, Raúl, et al.
Publicado: (2020) -
Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
por: Crespo, Carlos, et al.
Publicado: (2018) -
Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder
por: Wagg, Adrian
Publicado: (2012) -
Oxybutynin topical gel in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2010)